For over 20 years, studies have tried to measure the association between the duration of untreated psychosis (DUP) and changes in brain morphology. A hypothesis that untreated psychosis is neurotoxic has been postulated, but the mechanisms of that toxicity have not been described. We re-analyzed papers collected for a systematic review to extract data on the hypotheses that have been generated on the potential mechanisms by which DUP could impact brain morphology in first-episode psychosis. Dopaminergic hyperactivity, prolonged hypothalamic–pituitary–adrenal activation, and persistent activity of catecholamines have been hypothesized as mechanisms to explain these associations. However, the question remains as to whether the observed structural changes are permanent or may be reversed via antipsychotic treatment.
WyattRJ. Neuroleptics and the natural course of schizophrenia. Schizophr Bull. 1991;17(2):325–351.
2.
MarshallMLewisSLockwoodA, Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: A systematic review. Arch Gen Psychiatry. 2005;62(9):975–983. doi:10.1001/archpsyc.62.9.975.
3.
NormanRMGLewisSWMarshallM.Duration of untreated psychosis and its relationship to clinical outcome. Br J Psychiatry Suppl. 2005;48:s19–s23. doi:10.1192/bjp.187.48.s19.
4.
PerkinsDOGuHBotevaK, Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: A critical review and meta-analysis. Am J Psychiatry. 2005;162(10):1785–1804. doi:10.1176/appi.ajp.162.10.1785.
5.
PetersenLJeppesenPThorupA, A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. BMJ. 2005;331(7517):602. doi:10.1136/bmj.38565.415000.E01.
6.
BirdVPremkumarPKendallT, Early intervention services, cognitive-behavioural therapy and family intervention in early psychosis: Systematic review. Br J Psychiatry. 2010;197(5):350–356. doi:10.1192/bjp.bp.109.074526.
7.
HarveyPLepageMMallaA.Benefits of enriched intervention compared with standard care for patients with recent-onset psychosis: A metaanalytic approach. Can J Psychiatry. 2007;52(7):464–472.
8.
MihalopoulosCHarrisMHenryL, Is early intervention in psychosis cost-effective over the long term?Schizophr Bull. 2009;35(5):909–918. doi:10.1093/schbul/sbp054.
9.
GoldbergKNormanRHochJS, Impact of a specialized early intervention service for psychotic disorders on patient characteristics, service use, and hospital costs in a defined catchment area. Can J Psychiatry. 2006;51(14):895–903.
10.
McCronePCraigTKJPowerP, Cost-effectiveness of an early intervention service for people with psychosis. Br J Psychiatry. 2010;196(5):377–382. doi:10.1192/bjp.bp.109.065896.
11.
MoncrieffJLeoJ.A systematic review of the effects of antipsychotic drugs on brain volume. Psychol Med. 2010;40(9):1409–1422. doi:10.1017/S0033291709992297.
12.
NavariSDazzanP.Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings. Psychol Med. 2009;39(11):1763–1777. doi:10.1017/S0033291709005315.
13.
Fusar-PoliPSmieskovaRKemptonMJ, Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neurosci Biobehav Rev. 2013;37(8):1680–1691. doi:10.1016/j.neubiorev.2013.06.001.
14.
TorresUSPortela-OliveiraEBorgwardtS, Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: An activation likelihood estimation meta-analysis. BMC Psychiatry. 2013;13:342. doi:10.1186/1471–244X-13-342.
15.
BangaloreSSPrasadKMRMontroseDM, Cannabis use and brain structural alterations in first episode schizophrenia—a region of interest, voxel based morphometric study. Schizophr Res. 2008;99(1–3):1–6. doi:10.1016/j.schres.2007.11.029.
16.
RaisMCahnWvan HarenN, Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. Am J Psychiatry. 2008;165(4):490–496. doi:10.1176/appi. ajp.2007.07071110.
17.
ZipurskyRBReillyTJMurrayRM. The myth of schizophrenia as a progressive brain disease. Schizophr Bull. 2013;39(6):1363–72. doi:10.1093/schbul/sbs135.
18.
RundBR. Does active psychosis cause neurobiological pathology? A critical review of the neurotoxicity hypothesis. Psychol Med. 2013:1–14. doi:10.1017/S0033291713002341.
19.
MallaAKNormanRMGManchandaR, One year outcome in first episode psychosis: Influence of DUP and other predictors. Schizophr Res. 2002;54(3):231–242.
20.
StroupDFBerlinJAMortonSC, Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–2012.
21.
BangaloreSSGoradiaDDNutcheJ, Untreated illness duration correlates with gray matter loss in first-episode psychoses. Neuroreport. 2009;20(7):729–734. doi:10.1097/WNR.0b013e32832ae501.
22.
Crespo-FacorroBRoiz-SantiáñezRPelayo-TeránJM, Caudate nucleus volume and its clinical and cognitive correlations in first episode schizophrenia. Schizophr Res. 2007;91(1–3):87–96. doi:10.1016/j.schres.2006.12.015.
23.
Crespo-FacorroBRoiz-SantiáñezRPelayo-TeránJM, Reduced thalamic volume in first-episode non-affective psychosis: Correlations with clinical variables, symptomatology and cognitive functioning. Neuroimage. 2007;35(4):1613–1623. doi:10.1016/j.neuroimage.2007.01.048.
24.
KeshavanMSHaasGLKahnCE, Superior temporal gyrus and the course of early schizophrenia: Progressive, static, or reversible?J Psychiatr Res. 1998;32(3–4):161–167.
25.
LappinJMMorganKMorganC, Gray matter abnormalities associated with duration of untreated psychosis. Schizophr Res. 2006;83(2–3):145–153. doi:10.1016/j.schres.2005.11.018.
26.
MadsenALKarleARubinP, Progressive atrophy of the frontal lobes in first-episode schizophrenia: Interaction with clinical course and neuroleptic treatment. Acta Psychiatr Scand. 1999;100(5):367–374.
27.
MallaAKBodnarMJooberR, Duration of untreated psychosis is associated with orbital-frontal grey matter volume reductions in first episode psychosis. Schizophr Res. 2011;125(1):13–20. doi:10.1016/j.schres.2010.09.021.
28.
MandlRCWRaisMvan BaalGCM, Altered white matter connectivity in never-medicated patients with schizophrenia. Hum Brain Mapp. 2013;34(9):2353–2365. doi:10.1002/hbm.22075.
29.
Tauscher-WisniewskiSTauscherJChristensenBK, Volumetric MRI measurement of caudate nuclei in antipsychotic-naive patients suffering from a first episode of psychosis. J Psychiatr Res. 2005;39(4):365–370. doi:10.1016/j.jpsychires.2004.10.001.
30.
SimantovRBlinderERatovitskiT, Dopamine-induced apoptosis in human neuronal cells: Inhibition by nucleic acids antisense to the dopamine transporter. Neuroscience. 1996;74(1):39–50.
31.
ChakosMHLiebermanJABilderRM, Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry. 1994;151(10):1430–1436.
32.
GurREMaanyVMozleyPD, Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am J Psychiatry. 1998;155(12):1711–1717.
33.
KeshavanMS. Development, disease and degeneration in schizophrenia: A unitary pathophysiological model. J Psychiatr Res. 1999;33(6):513–521.
34.
WeinbergerDRCannon-SpoorEPotkinSG, Poor premorbid adjustment and CT scan abnormalities in chronic schizophrenia. Am J Psychiatry. 1980;137(11):1410–1413.
35.
VerdouxHBergeyCAssensF, Prediction of duration of psychosis before first admission. Eur Psychiatry. 1998;13(7):346–352. doi:10.1016/S0924–9338(99)80701–9.
36.
McGlashanTH. Is active psychosis neurotoxic?Schizophr Bull. 2006;32(4):609–613. doi:10.1093/schbul/sb1032.
37.
ComptonMTCarterTBergnerE, Defining, operationalizing and measuring the duration of untreated psychosis: Advances, limitations and future directions. Early Interv Psychiatry. 2007;1(3):236–250. doi:10.1111/j.1751–7893.2007.00036.x.
